NEVVI Medicare utilization intelligence

← back

LEVY, MICHELLEM.D. NPI 1851667596 Clinician

Hematology-Oncology · DENVER, CO

Specialty Hematology-Oncology — from billed Medicare claims
Trained EMORY UNIVERSITY SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 14 years since medical school (class of 2012, self-reported to CMS)
Location DENVER, CO · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 71 codes billed · 55,920 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
ROCKY MOUNTAIN CANCER CENTERS LLP
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2025-02

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J1453 Injection, fosaprepitant, 1 mg
J1756 Injection, iron sucrose, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J0897 Injection, denosumab, 1 mg
J0185 Injection, aprepitant, 1 mg
J1930 Injection, lanreotide, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
82784 Gammaglobulin (immune system protein) measurement
88185 Flow cytometry technique for dna or cell analysis, each additional marker
J1626 Injection, granisetron hydrochloride, 100 mcg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J0640 Injection, leucovorin calcium, per 50 mg
36415 Insertion of needle into vein for collection of blood sample
J9190 Injection, fluorouracil, 500 mg
83615 Lactate dehydrogenase (enzyme) level
A9595 Piflufolastat f-18, diagnostic, 1 millicurie
J3489 Injection, zoledronic acid, 1 mg
83521 Measurement of immunoglobulin light chains
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96413 Administration of chemotherapy into vein, 1 hour or less
96375 Injection of additional new drug or substance into vein
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
85055 Reticulated (young) platelet measurement
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
84165 Protein measurement, serum
86334 Immunologic analysis technique on serum (immunofixation)
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
84550 Uric acid level, blood
96372 Injection of drug or substance under skin or into muscle
83735 Magnesium level
A9587 Gallium ga-68, dotatate, diagnostic, 0.1 millicurie
82232 Beta-2 microglobulin (protein) level
85046 Red blood count automated, with additional calculations
84100 Phosphate level
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
82728 Ferritin (blood protein) level
J7030 Infusion, normal saline solution , 1000 cc
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
85007 Microscopic examination for white blood cells with manual cell count
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
J1200 Injection, diphenhydramine hcl, up to 50 mg
96417 Administration of additional new drug or substance into vein, 1 hour or less
83540 Iron level
83550 Iron binding capacity
96360 Infusion into a vein for hydration, 31-60 minutes
96415 Administration of chemotherapy into vein, each additional hour
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
96411 Administration of additional new drug or substance into vein using push technique
96361 Infusion into a vein for hydration, each additional hour
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
J3490 Unclassified drugs
88184 Flow cytometry technique for dna or cell analysis, first marker
78816 Nuclear medicine study whole body with ct scan
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
79101 Radioactive drug therapy through a vein
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
38222 Biopsy and aspiration of bone marrow sample for diagnosis
74177 Ct scan of abdomen and pelvis with contrast
71260 Ct scan of chest with contrast
82607 Cyanocobalamin (vitamin b-12) level
71250 Ct scan of chest without contrast

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.